78 results
Page 3 of 4
6-K
EX-99.2
6oq6ykfwehvnax5v4fq2
10 Dec 20
Current report (foreign)
6:03am
6-K
EX-99.1
oa2y8
10 Dec 20
Current report (foreign)
6:03am
6-K
EX-99.1
q0wwc 204b5vpbs
24 Nov 20
Current report (foreign)
6:03am
6-K
EX-1.1
mgd1u7vzzfj3jwte0jr
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
424B5
w1833lfomo mitmf
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.1
rpuz0twrat
14 Aug 20
Current report (foreign)
4:24pm
6-K
EX-99.3
chwu6rsf0b dg
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
29beaepj9qt2v65e7
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
07mexa5u045kjkjp3hp
7 Jul 20
Current report (foreign)
3:39pm
6-K
EX-99.1
mhudo 8lb1l91
4 Jun 20
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
6:11am
6-K
EX-99.3
2icx7sj ts0zk
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
fapkplnp7jgiqw ebr
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
41gtpybg z8feotzni2u
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.3
sba563k1w ltgbhnv5ql
7 Nov 19
Current report (foreign)
9:11am
F-3
EX-4.1
buurhqdke cb3g5
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
lwv5jpj0
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.3
ct735mbfo4pbigiqqzg
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
nksy3us
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am